Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more ...

AP402 targets p95HER2, a truncated form of HER2 present in 30-40% of HER2-positive cancers, which is associated with exceptionally poor prognosis, and not addressable by conventional anti-HER2 ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

We are pleased to have secured this term loan facility ahead of important anticipated catalysts, including gaining alignment with the FDA on the regulatory pathway of our pipeline candidate, VYD2311,” ...

There's nothing better than a beautiful spring day after a long, cold winter. But there's nothing worse than having that day ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers evaluated the safety and immune response of a poultry-derived H5N1 avian influenza vaccine in black vultures and ...

For one, microglia hovering around plaques—the type that express the most TREM2—reportedly become desensitized to stimulation ...